MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

375.82 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 158
Open 375.82
Bid (Size) 373.13 (40)
Ask (Size) 376.87 (40)
Prev. Close 375.82
Today's Range 375.82 - 375.82
52wk Range 261.43 - 385.12
Shares Outstanding 538,500,000
Dividend Yield 2.53%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts
In a dramatic week for the pharmaceutical sector, a stark rift has opened between the two undisputed titans of the weight-loss drug market. On February 4, 2026, Eli Lilly (NYSE:LLY) reported a... 
Via MarketMinute
Topics Earnings Economy
News headline image
Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports ↗
The medications that will be offered via the platform include Novo Nordisk’s popular weight-loss drug Wegovy, Eli Lilly and Company's Zepbound, Amgen’s cholesterol drug Repatha, and Merck’s diabetes... 
Via Stocktwits
Topics Economy Government World Trade

Performance

YTD
+14.7%
+14.7%
1 Month
+15.4%
+15.4%
3 Month
+16.1%
+16.1%
6 Month
+31.8%
+31.8%
1 Year
+27.5%
+27.5%

More News

Read More
News headline image
Healthcare Titans Propel Dow to Record Highs as GLP-1 Sales Spark Major Market Rotation
Via MarketMinute
Topics Artificial Intelligence Earnings Intellectual Property
Amgen CEO Teases 2026 As ‘Springboard Year’ After 14 Blockbusters And 18 Record Products ↗
Via Stocktwits
Amgen Inc (NASDAQ:AMGN) Beats Q4 2025 Estimates and Provides Strong 2026 Revenue Guidance ↗
Via Chartmill
News headline image
These 2 Companies Could Soon Join the Weight Loss Market: Are They Buys? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The $1 Trillion Apothecary: A Deep-Dive Research Report on Eli Lilly (LLY)
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
Why Is Amgen Stock Falling Premarket? ↗
Via Stocktwits
AMGEN INC (NASDAQ:AMGN) Shows High Technical and Setup Ratings for Potential Breakout ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
AMGN Q4 Deep Dive: Product Portfolio Expansion and Pipeline Progress Drive Outlook
Via StockStory
News headline image
Amgen (AMGN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025
Via StockStory
News headline image
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
Via MarketMinute
Topics ETFs Government Initial Public Offering
News headline image
Amgen (AMGN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
News headline image
Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy. ↗
Via The Motley Fool
News headline image
The $100 Billion Milestone: Johnson & Johnson Pivots from 'Steady' 2025 to Growth-Focused 2026
Via MarketMinute
Topics Earnings Economy Government
News headline image
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
Via Finterra
Topics Economy Initial Public Offering
News headline image
Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
News headline image
The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era
Via MarketMinute
Topics Economy
News headline image
Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth
Via MarketMinute
Topics Earnings Economy Intellectual Property
News headline image
The 50.9 Mirage: Is the Manufacturing Expansion a True Recovery or a Tariff-Induced Sugar High?
Via MarketMinute
Topics Economy Supply Chain World Trade

Frequently Asked Questions

Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 375.82
When was Amgen last traded?
The last trade of Amgen was at 02/09/26 04:00 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 202.38B
How many shares of Amgen are outstanding?
Amgen has 202B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story